China Universal Asset Management Company’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $217K | Buy |
22,829
+139
| +0.6% | +$1.32K | 0.02% | 306 |
|
|
2025
Q1 | $237K | Buy |
22,690
+1,115
| +5% | +$11.7K | 0.02% | 295 |
|
|
2024
Q4 | $508K | Buy |
21,575
+2,265
| +12% | +$53.4K | 0.05% | 248 |
|
|
2024
Q3 | $694K | Buy |
19,310
+7,812
| +68% | +$281K | 0.08% | 178 |
|
|
2024
Q2 | $406K | Sell |
11,498
-4,075
| -26% | -$144K | 0.06% | 164 |
|
|
2024
Q1 | $442K | Buy |
15,573
+8,474
| +119% | +$241K | 0.06% | 193 |
|
|
2023
Q4 | $94.4K | Buy |
7,099
+5,541
| +356% | +$73.7K | 0.02% | 286 |
|
|
2023
Q3 | $14K | Buy |
1,558
+794
| +104% | +$7.11K | ﹤0.01% | 322 |
|
|
2023
Q2 | $8.6K | Buy |
764
+58
| +8% | +$653 | ﹤0.01% | 329 |
|
|
2023
Q1 | $8.13K | Buy |
706
+176
| +33% | +$2.03K | ﹤0.01% | 320 |
|
|
2022
Q4 | $6.14K | Buy |
530
+46
| +10% | +$533 | ﹤0.01% | 274 |
|
|
2022
Q3 | $6K | Buy |
+484
| New | +$6K | ﹤0.01% | 249 |
|